Biochemical characterization of a cancer immunotherapeutic agent: MSF-MB.
D000276:Adjuvants, Immunologic / Q000032:analysis*; D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D001428:Bacterial Vaccines / Q000032:analysis* / Q000627:therapeutic use; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D006386:Hemagglutination Tests; D008041:Linoleic Acids / Q000032:analysis; D008055:Lipids / Q000032:analysis / Q000494:pharmacology; D009161:Mycobacterium / Q000276:immunology*; D009369:Neoplasms / Q000628:therapy*; D009829:Oleic Acids / Q000032:analysis; D010169:Palmitic Acids / Q000032:analysis; D010743:Phospholipids / Q000032:analysis; D051381:Rats; D014885:Waxes / Q000032:analysis
D000276:Adjuvants, Immunologic; D001428:Bacterial Vaccines; D008041:Linoleic Acids; D008055:Lipids; D009829:Oleic Acids; D010169:Palmitic Acids; D010743:Phospholipids; D014885:Waxes